Study for Safety and Efficacy Evaluation of Imatinib Mesylate in Children With Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+)
Clinical trial NCT01222013 · SUSPENDED
Trial details
- NCT number
- NCT01222013
- Sponsor
- Renato Melaragno
- Status
- SUSPENDED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.